Table II.
Clinical characteristics and outcomes of locally advanced unresectable pancreatic ductal adenocarcinoma in patients who underwent conversion surgery following gemcitabine plus nab-paclitaxel therapy.
| No. | Operation method | Curability | Evans' criteria | OS from initial treatment (months) | Survival |
|---|---|---|---|---|---|
| 1 | PD | R0 | IIa | 14 | No |
| 2 | PD-CAR, PVR | R0 | I | 33 | Yes |
| 3 | DP-CAR, PVR | R0 | IIa | 30 | No |
| 4 | DP-CAR | R0 | IIa | 15 | No |
| 5 | PD, PVR | R1 | IIa | 16 | No |
| Present case | PD, PVR | R0 | IIa | 19 | Yes |
DP-CAR, distal pancreatectomy with en block celiac axis resection; OS, overall survival; PD, pancreaticoduodenectomy; PVR, portal vein resection; PD-CAR, pancreaticoduodenectomy with en block common hepatic artery resection.